CompletedNot Applicable

Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?

Turkey (Türkiye)95 participantsStarted 2024-06-01

Plain-language summary

Purpose: This study aims to examine the effectiveness of the Swede score and 2011 IFCPC Nomenclature in hr-HPV carriers and evaluate diagnostic sensitivity and specificity according to hr-HPV types and multiple HPV carrier status. Methods: This study included 95 women with high-risk HPV. Colposcopic findings were scored using the Swede Score and the 2011 IFCPC system to predict pathology. Accuracy, sensitivity, specificity, PPV and NPV were calculated.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who are positive for at least 1 type of high-risk HPV. * Women with high-risk HPV and subjective symptoms such as post-coital bleeding or prolonged leucorrhoea were included in the study. Exclusion Criteria: * Women with normal colposcopy findings, as defined by both the 2011 IFCPC system and the Swede score * Pregnant women

What they're measuring

The comparison of diagnostic power of the Swede Score and 2011 IFCPC Nomenclature in patients with hr-HPV

Timeframe: 6 months

Trial details

NCT IDNCT07012356

SponsorNecmettin Erbakan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-30

View on ClinicalTrials.gov More Colposcopy trials